{"id":38134,"date":"2018-03-28T19:19:35","date_gmt":"2018-03-28T17:19:35","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=38134"},"modified":"2018-03-28T19:19:35","modified_gmt":"2018-03-28T17:19:35","slug":"farmaceutic-davant-pacient-insuficiencia-cardiaca","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/","title":{"rendered":"El farmac\u00e9utico frente al paciente con insuficiencia card\u00edaca"},"content":{"rendered":"<p>El pasado 22 de marzo tuvo lugar el curso <strong>&quot;El paciente con insuficiencia card\u00edaca&quot;<\/strong>, dirigido a farmac\u00e9uticos comunitarios, de hospitales, de centros de atenci\u00f3n primaria y de la administraci\u00f3n sanitaria. La formaci\u00f3n profundiz\u00f3 en las bases y las <strong>recomendaciones necesarias para orientar al profesional sanitario en la gesti\u00f3n del paciente con insuficiencia card\u00edaca<\/strong> (IC) con las mejores estrategias de gesti\u00f3n de un paciente individual con una condici\u00f3n dada.<\/p>\n<figure id=\"attachment_38189\" aria-describedby=\"caption-attachment-38189\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/Formaci\u00f3-insufici\u00e8ncia-card\u00edaca.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-38189 size-large\" title=\"El aula del COFB llena frente al gran inter\u00e9s despertado por esta formaci\u00f3n.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/Formaci\u00f3-insufici\u00e8ncia-card\u00edaca-1024x585.jpg\" alt=\"L'aula del COFB plena davant el gran inter\u00e8s despertat per aquesta formaci\u00f3.\" width=\"620\" height=\"354\" \/><\/a><figcaption id=\"caption-attachment-38189\" class=\"wp-caption-text\">El aula del COFB llena frente al gran inter\u00e9s despertado por esta formaci\u00f3n.<\/figcaption><\/figure>\n<p>Estas recomendaciones pretend\u00edan ofrecer ayuda a los profesionales de la salud para tomar decisiones en la pr\u00e1ctica diaria de cara a que la respuesta asistencial sea eficaz y hecha desde un enfoque asistencial compartido y de colaboraci\u00f3n entre profesionales y organizaciones con el objetivo final mejorar la calidad de vida del paciente.<\/p>\n<h1><strong>Estilos de vida, tratamientos farmacoterap\u00e9uticos, gesti\u00f3n del paciente\u2026<\/strong><\/h1>\n<p>Los diversos \u00e1mbitos tratados en la formaci\u00f3n fueron:<\/p>\n<ul>\n<li>Saber hacer <strong>recomendaciones de salud y estilo de vida para prevenir<\/strong> o retrasar la aparici\u00f3n de la IC.<\/li>\n<li>Actualizar y <strong>profundizar en los tratamientos farmacoterap\u00e9uticos<\/strong> indicados, la evidencia cient\u00edfica de cada tratamiento y la combinaci\u00f3n de estos f\u00e1rmacos. Conocer las complicaciones y las comorbilidades asociadas.<\/li>\n<li>Identificar c\u00f3mo se gestiona actualmente <strong>el paciente con IC<\/strong>.<\/li>\n<li>Detectar <strong>problemas relacionados con los medicamentos<\/strong> (PRM): las interacciones, la dificultad de adherencia y el incumplimiento terap\u00e9utico, entre otros.<\/li>\n<li>Conocer las <strong>transacciones asistenciales<\/strong> del paciente desde el diagn\u00f3stico y descompensaciones hasta fases avanzadas de la enfermedad.<\/li>\n<li>Integrar y mejorar la <strong>comunicaci\u00f3n y la coordinaci\u00f3n del equipo asistencial<\/strong> para mejorar la calidad de vida del paciente con IC.<\/li>\n<\/ul>\n<div class=\"destacat-blog\">\n<h2>\u00bfCu\u00e1l fue el programa?<\/h2>\n<p><strong>Paciente con insuficiencia card\u00edaca (IC)<\/strong><br \/>\n\u00b7Introducci\u00f3n y epidemiolog\u00eda cl\u00ednica.<br \/>\n\u00b7Estilos de vida, factores de riesgo, factores de riesgo desencadenantes y actividades preventivas.<br \/>\n\u00b7Proceso diagn\u00f3stico.<br \/>\n<strong>Farmacoterap\u00e9utica de la IC<\/strong><br \/>\n\u00b7Tratamiento farmacol\u00f3gico.<br \/>\n\u00b7Titulaci\u00f3n y tratamiento sintom\u00e1tico.<br \/>\n\u00b7 Detecci\u00f3n de interacciones, problemas relacionados con los medicamentos (PRM), complicaciones y adherencia.<br \/>\n<strong>Comorbilidades<\/strong><br \/>\n\u00b7Cardiovasculares.<br \/>\n\u00b7Extracard\u00edacas.<br \/>\n<strong>Transici\u00f3n entre niveles asistenciales<br \/>\n<\/strong><strong>Enfermedad avanzada: <\/strong>necesidades paliativas, tratamiento sintom\u00e1tico y atenci\u00f3n centrada en la persona.<br \/>\n<strong>Debate: <\/strong>\u00bfqu\u00e9 espera el paciente experto?<\/p>\n<\/div>\n<h1><strong>Participaci\u00f3n activa de los alumnos<\/strong><\/h1>\n<p>La sesi\u00f3n formativa, metodol\u00f3gicamente hablando, se bas\u00f3 en la <strong>reflexi\u00f3n conjunta de distintos especialistas con puntos de vista diversos sobre las estrategias de prevenci\u00f3n, control y tratamiento de la insuficiencia card\u00edaca<\/strong>.<\/p>\n<figure id=\"attachment_38197\" aria-describedby=\"caption-attachment-38197\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/Formaci\u00f3-insufici\u00e8ncia-card\u00edaca_coordinador.jpg\"><img decoding=\"async\" class=\"wp-image-38197 size-large\" title=\"Antonio S\u00e1nchez Hidalgo, jefe de Servicio de Cardiolog\u00eda en el Consorcio Sanitario de Terrassa, introdujo el curso como coordinador del mismo\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/Formaci\u00f3-insufici\u00e8ncia-card\u00edaca_coordinador-1024x640.jpg\" alt=\"Antonio S\u00e1nchez Hidalgo, cap de Servei de Cardiologia al Consorci Sanitari de Terrassa, va introduir el curs com a coordinador del mateix\" width=\"620\" height=\"388\" \/><\/a><figcaption id=\"caption-attachment-38197\" class=\"wp-caption-text\">Antonio S\u00e1nchez Hidalgo, jefe de Servicio de Cardiolog\u00eda en el Consorcio Sanitario de Terrassa, introdujo el curso como coordinador del mismo.<\/figcaption><\/figure>\n<p>Se desarroll\u00f3 de una<strong> forma din\u00e1mica y participativa en torno a la historia de un paciente con IC<\/strong> desde el diagn\u00f3stico hasta fases avanzadas de la enfermedad teniendo en cuenta las diferentes situaciones en las que el farmac\u00e9utico se puede encontrar y en las que puede intervenir o todo lo que necesita saber en cuanto al <strong>tratamiento, adherencia, descompensaciones y transacciones<\/strong>. Al t\u00e9rmino de la jornada, hubo un debate conjunto de los puntos clave expuestos.<\/p>\n<div class=\"destacat-blog\">\n<h1>Equipo docente<\/h1>\n<p><strong>Brugada, Montserrat<\/strong>, enfermera, gesti\u00f3n de casos, UGAP 3-4 Santa Coloma de Gramanet, Barcelona<br \/>\n<strong>De la Higuera, Mariano<\/strong>, m\u00e9dico de familia, EAP Cerde\u00f1a, Barcelona<br \/>\n<strong>Fernandez, Mercedes<\/strong>, paciente cr\u00f3nica experta<br \/>\n<strong>Freixa, Roman<\/strong>, cardi\u00f3logo, jefe del Servicio de Cardiolog\u00eda, Hospital Mois\u00e8s Broggi, Sant Joan Desp\u00ed\/L&#039;Hospitalet de Llobregat<br \/>\n<strong>Iracheta, Montse<\/strong>, farmac\u00e9utica comunitaria en Santa Coloma de Gramanet, vocal de la ejecutiva catalana de la SEFAC, profesora asociada de la Facultad de Farmacia (UB)<br \/>\n<strong>Molist, N\u00faria<\/strong>, geriatra, Hospital de la Santa Cruz, Vic<br \/>\n<strong>Roca, Mariona<\/strong>, farmac\u00e9utica de atenci\u00f3n primaria, Consorcio Sanitario de Terrassa-Servicio de farmacia integral<br \/>\n<strong>Tous, Salvador<\/strong>, farmac\u00e9utico comunitario en Barcelona, vocal de la ejecutiva catalana de la SEFAC, m\u00e1ster de informaci\u00f3n y consejo sanitario en la oficina de farmacia<\/p>\n<\/div>\n<p><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/Novartis.jpg\"><img decoding=\"async\" class=\"size-full wp-image-38136 alignright\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/Novartis.jpg\" alt=\"\" width=\"262\" height=\"73\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><b>Otras publicaciones relacionadas recogidas en el Blog:<\/b><\/p>\n<ul>\n<li><a href=\"https:\/\/blog.cofb.cat\/la-figura-del-farmaceutic-necessaria-en-la-ruta-assistencial-de-la-insuficiencia-cardiaca-la-fibril%C2%B7lacio-auricular\/\" target=\"_blank\" rel=\"noopener\"><span class=\"current\">La figura del farmac\u00e9utico, necesaria en la ruta asistencial de la insuficiencia card\u00edaca y la fibrilaci\u00f3n auricular (Abril 2017)<\/span><\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/cap-on-va-la-recerca-en-sindrome-coronaria-aguda-i-insuficiencia-cardiaca\/\" target=\"_blank\" rel=\"noopener\">\u00bfHacia d\u00f3nde va la investigaci\u00f3n en s\u00edndrome coronario agudo e insuficiencia card\u00edaca? (Febrero 2015)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/atencio-farmaceutica-a-pacients-amb-insuficiencia-cardiaca\/\" target=\"_blank\" rel=\"noopener\">Atenci\u00f3n farmac\u00e9utica a pacientes con insuficiencia card\u00edaca (Abril 2014)<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>El pasado 22 de marzo tuvo lugar el curso \u201cEl paciente con insuficiencia card\u00edaca\u201d, dirigido a farmac\u00e9uticos comunitarios, hospitales, centros de atenci\u00f3n primaria y administraci\u00f3n sanitaria. La formaci\u00f3n profundiz\u00f3 en las bases y recomendaciones necesarias para orientar al profesional sanitario en la gesti\u00f3n del paciente con insuficiencia [\u2026]<\/p>","protected":false},"author":1,"featured_media":38189,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2187,2877,64,2881,2799,2729,91,2744,2198,290,2745],"class_list":["post-38134","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-adherencia","tag-administracio-sanitaria","tag-atencio-farmaceutica","tag-farmaceutic-atencio-primaria","tag-farmaceutic-comunitari","tag-farmaceutic-dhospital","tag-farmacoterapia","tag-insuficiencia-cardiaca","tag-malalties-cardiovasculars","tag-pacient","tag-prm"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 22 de mar\u00e7 va tenir lloc el curs &#8220;El pacient amb insufici\u00e8ncia card\u00edaca&#8221;, adre\u00e7at a farmac\u00e8utics comunitaris, d\u2019hospitals, de centres d\u2019atenci\u00f3 prim\u00e0ria i de l\u2019administraci\u00f3 sanit\u00e0ria. La formaci\u00f3 va aprofundir\u00a0en les bases i les recomanacions necess\u00e0ries per orientar el professional sanitari en la gesti\u00f3 del pacient amb insufici\u00e8ncia [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-28T17:19:35+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca\",\"datePublished\":\"2018-03-28T17:19:35+00:00\",\"dateModified\":\"2018-03-28T17:19:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/\"},\"wordCount\":745,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"adher\u00e8ncia\",\"Administraci\u00f3 Sanit\u00e0ria\",\"Atenci\u00f3 farmac\u00e8utica\",\"farmac\u00e8utic atenci\u00f3 prim\u00e0ria\",\"farmac\u00e8utic comunitari\",\"farmac\u00e8utic d'hospital\",\"farmacoter\u00e0pia\",\"insufici\u00e8ncia card\u00edaca\",\"malalties cardiovasculars\",\"pacient\",\"PRM\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/\",\"name\":\"El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2018-03-28T17:19:35+00:00\",\"dateModified\":\"2018-03-28T17:19:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/","og_locale":"es_ES","og_type":"article","og_title":"El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 22 de mar\u00e7 va tenir lloc el curs &#8220;El pacient amb insufici\u00e8ncia card\u00edaca&#8221;, adre\u00e7at a farmac\u00e8utics comunitaris, d\u2019hospitals, de centres d\u2019atenci\u00f3 prim\u00e0ria i de l\u2019administraci\u00f3 sanit\u00e0ria. La formaci\u00f3 va aprofundir\u00a0en les bases i les recomanacions necess\u00e0ries per orientar el professional sanitari en la gesti\u00f3 del pacient amb insufici\u00e8ncia [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2018-03-28T17:19:35+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca","datePublished":"2018-03-28T17:19:35+00:00","dateModified":"2018-03-28T17:19:35+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/"},"wordCount":745,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#primaryimage"},"thumbnailUrl":"","keywords":["adher\u00e8ncia","Administraci\u00f3 Sanit\u00e0ria","Atenci\u00f3 farmac\u00e8utica","farmac\u00e8utic atenci\u00f3 prim\u00e0ria","farmac\u00e8utic comunitari","farmac\u00e8utic d'hospital","farmacoter\u00e0pia","insufici\u00e8ncia card\u00edaca","malalties cardiovasculars","pacient","PRM"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/","url":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/","name":"El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#primaryimage"},"thumbnailUrl":"","datePublished":"2018-03-28T17:19:35+00:00","dateModified":"2018-03-28T17:19:35+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2018\/03\/28\/farmaceutic-davant-pacient-insuficiencia-cardiaca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"El farmac\u00e8utic davant el pacient amb insufici\u00e8ncia card\u00edaca"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 22 de mar\u00e7 va tenir lloc el curs &#8220;El pacient amb insufici\u00e8ncia card\u00edaca&#8221;, adre\u00e7at a farmac\u00e8utics comunitaris, d\u2019hospitals, de centres d\u2019atenci\u00f3 prim\u00e0ria i de l\u2019administraci\u00f3 sanit\u00e0ria. La formaci\u00f3 va aprofundir\u00a0en les bases i les recomanacions necess\u00e0ries per orientar el professional sanitari en la gesti\u00f3 del pacient amb insufici\u00e8ncia [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/38134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=38134"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/38134\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=38134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=38134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=38134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}